Palouse Capital Management, Inc. Abb Vie Inc. Transaction History

Palouse Capital Management, Inc.

$154 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $8.06 Million - $10 Million	-61,063 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $476,559 - $602,985	-4,436 Reduced 6.77%	61,063 $8.27 Million
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $7.23 Million - $8.21 Million	-67,978 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $1,998 - $2,226	-19 Reduced 0.03%	67,978 $7.66 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $172,273 - $189,652	-1,684 Reduced 2.42%	67,997 $7.36 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $485,435 - $655,388	-6,031 Reduced 7.97%	69,681 $7.47 Million
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $1.3 Million - $1.52 Million	-15,081 Reduced 16.61%	75,712 $6.63 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $6.66 Million - $8.91 Million	90,793 New	90,793 $8.91 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $6.68 Million - $10.1 Million	-103,563 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $7.47 Million - $9.35 Million	103,563 New	103,563 $9.17 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $7.18 Million - $8.64 Million	-114,067 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $2.78 Million - $3.56 Million	42,342 Added 59.03%	114,067 $8.3 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $537,588 - $632,715	6,969 Added 10.76%	71,725 $5.78 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $55,039 - $67,879	-707 Reduced 1.08%	64,756 $5.97 Million
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $34,941 - $38,844	-393 Reduced 0.6%	65,463 $6.19 Million
Q2 2018 Jul 27, 2018	SELL	$89.78 - $106.23 $81,071 - $95,925	-903 Reduced 1.35%	65,856 $6.1 Million
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $12,329 - $16,510	134 Added 0.2%	66,759 $6.32 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $70,304 - $77,094	-785 Reduced 1.16%	66,625 $6.44 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $4.71 Million - $6.01 Million	67,410	67,410 $5.99 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palouse Capital Management, Inc. with notifications on news.

Account